Emerald Mutual Fund Advisers Trust Ocular Therapeutix, Inc Transaction History

Emerald Mutual Fund Advisers Trust

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$2.61 - $4.41 $1.05 Million - $1.77 Million	-401,515 Reduced 37.11%	680,588 $1.91 Million
Q3 2022 Oct 25, 2022	BUY	$4.09 - $6.5 $152,847 - $242,911	37,371 Added 3.58%	1,082,103 $4.49 Million
Q2 2022 Jul 29, 2022	SELL	$3.01 - $5.22 $145,732 - $252,731	-48,416 Reduced 4.43%	1,044,732 $4.2 Million
Q1 2022 Apr 29, 2022	BUY	$4.83 - $7.35 $463,303 - $705,026	95,922 Added 9.62%	1,093,148 $5.41 Million
Q4 2021 Feb 02, 2022	BUY	$6.16 - $12.07 $3.83 Million - $7.5 Million	621,420 Added 165.36%	997,226 $6.95 Million

Q3 2021 Oct 28, 2021	SELL	$9.7 - $14.34 $9.15 Million - $13.5 Million	-942,931 Reduced 71.5%	375,806 $3.76 Million
Q2 2021 Jul 29, 2021	SELL	$13.43 - $19.16 $472,185 - $673,646	-35,159 Reduced 2.6%	1,318,737 $18.7 Million
Q1 2021 Apr 29, 2021	BUY	$15.82 - $22.11 $3.67 Million - $5.14 Million	232,268 Added 20.71%	1,353,896 $22.2 Million
Q4 2020 Jan 29, 2021	BUY	$7.91 - $22.95 $8.87 Million - $25.7 Million	1,121,628 New	1,121,628 $23.2 Million

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.